Porvair Sciences reports strong growing demand for their Chromatrap® chromatin immunoprecipitation (ChIP) assay technology from academic groups and biopharmaceutical organisations involved with epigenetic research.
Stephen Knight, Sales and Marketing Director commented "An expanding number of proven application solutions and the introduction of the Chromatrap® 96 HT solid-state ChIP high throughput platform has enabled us to more than double the number of research groups using ChromaTrap assay technology during the last 12 months". He added "We are particularly pleased by the very positive feedback from early adopters of the technology".
Brian J. Engel, a Biochemistry & Cell Biology researcher at Rice University, USA commented "What I like most about the Chromatrap kit compared to traditional bead-based ChIP assays is the ease of use, speed and reliability. There is no worry about accidentally losing beads during washes and reducing output chromatin when using the column-based method". His colleague - Curt Warren added "We have found that the Chromatrap kit is quick, reliable and flexible. Saving reagents and time with this kit makes it easier and more feasible to conduct more thorough and effective IP based experiments. With the enhanced reproducibility using Chromatrap, I would not go back to bead-based ChIP and the assay has been fully endorsed and adopted within our research team".
Professor Steve Conlan, Head of Molecular & Cell Biology at Swansea University, UK commented "Chromatrap streamlines the complicated experimental procedure associated with chromatin-IP making it a much quicker and user-friendly assay compared to conventional bead based assays. Using this kit we obtain much more consistent data, and most importantly can use much less input sample. We have made a permanent switch to using Chromatrap for all our cell line and primary cell based assays, and fully endorse the technology". Research assistant - Dr Helen Whiteland added "What I like about the Chromatrap assay is the ease of use and quick method allowing me to analyse my data in the same day".
For further information about Chromatrap® please visit www.chromatrap.com or contact Porvair Sciences on +44-1978-666239 / -240 or [email protected].
Established in 1992, Porvair Sciences Ltd. has developed internationally recognised expertise in microplate technology and manufacturing serving applications in Drug Discovery, Combinatorial Chemistry, Solid Phase Extraction, Protein Purification, High Throughput Screening, Environmental Analysis, Proteomics and Genomics. Porvair Sciences Ltd. is a wholly owned subsidiary of Porvair plc.